151 related articles for article (PubMed ID: 38360515)
21. Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortium.
Lee MD; Patel SH; Mohan S; Akbari H; Bakas S; Nasrallah MP; Calabrese E; Rudie J; Villanueva-Meyer J; LaMontagne P; Marcus DS; Colen RR; Balana C; Choi YS; Badve C; Barnholtz-Sloan JS; Sloan AE; Booth TC; Palmer JD; Dicker AP; Flanders AE; Shi W; Griffith B; Poisson LM; Chakravarti A; Mahajan A; Chang S; Orringer D; Davatzikos C; Jain R;
Neuroradiology; 2023 Sep; 65(9):1343-1352. PubMed ID: 37468750
[TBL] [Abstract][Full Text] [Related]
22. Clinical and imaging characteristics of supratentorial glioma with IDH2 mutation.
Ikeda S; Sakata A; Arakawa Y; Mineharu Y; Makino Y; Takeuchi Y; Fushimi Y; Okuchi S; Nakajima S; Otani S; Nakamoto Y
Neuroradiology; 2024 Jun; 66(6):973-981. PubMed ID: 38653782
[TBL] [Abstract][Full Text] [Related]
23. Comparison of diagnostic performance of radiologist- and AI-based assessments of T2-FLAIR mismatch sign and quantitative assessment using synthetic MRI in the differential diagnosis between astrocytoma, IDH-mutant and oligodendroglioma, IDH-mutant and 1p/19q-codeleted.
Kikuchi K; Togao O; Yamashita K; Momosaka D; Kikuchi Y; Kuga D; Yuhei S; Fujioka Y; Narutomi F; Obara M; Yoshimoto K; Ishigami K
Neuroradiology; 2024 Mar; 66(3):333-341. PubMed ID: 38224343
[TBL] [Abstract][Full Text] [Related]
24. Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.
Kim M; Jung SY; Park JE; Jo Y; Park SY; Nam SJ; Kim JH; Kim HS
Eur Radiol; 2020 Apr; 30(4):2142-2151. PubMed ID: 31828414
[TBL] [Abstract][Full Text] [Related]
25. Comparison of MRI Sequences to Predict
Kasap DNG; Mora NGN; Blömer DA; Akkurt BH; Heindel WL; Mannil M; Musigmann M
Biomedicines; 2024 Mar; 12(4):. PubMed ID: 38672080
[TBL] [Abstract][Full Text] [Related]
26. Combining methionine-PET and MRI fluid-attenuated inversion-recovery mismatch to determine glioma molecular subtype.
Ohmura K; Kumagai N; Kumagai M; Ikegame Y; Shinoda J; Yano H; Muragaki Y; Iwama T
J Neuroimaging; 2023; 33(4):652-660. PubMed ID: 37158779
[TBL] [Abstract][Full Text] [Related]
27. T2-Fluid-Attenuated Inversion Recovery (FLAIR) Mismatch as a Novel Specific MRI Marker for Adult Low-Grade Glioma (LGG): A Case Report.
Slaghour RM; Almarshedi RA; Alzahrani AM; Albadr F
Cureus; 2022 Sep; 14(9):e29457. PubMed ID: 36299937
[TBL] [Abstract][Full Text] [Related]
28. Quantifying T2-FLAIR Mismatch Using Geographically Weighted Regression and Predicting Molecular Status in Lower-Grade Gliomas.
Mohammed S; Ravikumar V; Warner E; Patel SH; Bakas S; Rao A; Jain R
AJNR Am J Neuroradiol; 2022 Jan; 43(1):33-39. PubMed ID: 34764084
[TBL] [Abstract][Full Text] [Related]
29. [Predicting cerebral glioma enhancement pattern using a machine learning-based magnetic resonance imaging radiomics model].
He H; Guo E; Meng W; Wang Y; Wang W; He W; Wu Y; Yang W
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jan; 44(1):194-200. PubMed ID: 38293992
[TBL] [Abstract][Full Text] [Related]
30. The Histopathologic and Radiologic Features of T2-FLAIR Mismatch Sign in IDH-Mutant 1p/19q Non-codeleted Astrocytomas.
Fujita Y; Nagashima H; Tanaka K; Hashiguchi M; Hirose T; Itoh T; Sasayama T
World Neurosurg; 2021 May; 149():e253-e260. PubMed ID: 33610870
[TBL] [Abstract][Full Text] [Related]
31. Thin-Slice Magnetic Resonance Imaging-Based Radiomics Signature Predicts Chromosomal 1p/19q Co-deletion Status in Grade II and III Gliomas.
Kong Z; Jiang C; Zhang Y; Liu S; Liu D; Liu Z; Chen W; Liu P; Yang T; Lyu Y; Zhao D; You H; Wang Y; Ma W; Feng F
Front Neurol; 2020; 11():551771. PubMed ID: 33192984
[No Abstract] [Full Text] [Related]
32. Patterns of T2-FLAIR discordance across a cohort of adult-type diffuse gliomas and deviations from the classic T2-FLAIR mismatch sign.
Malik P; Soliman R; Chen YA; Munoz DG; Das S; Bharatha A; Mathur S
Neuroradiology; 2024 Apr; 66(4):521-530. PubMed ID: 38347151
[TBL] [Abstract][Full Text] [Related]
33. Radiographic assessment of contrast enhancement and T2/FLAIR mismatch sign in lower grade gliomas: correlation with molecular groups.
Juratli TA; Tummala SS; Riedl A; Daubner D; Hennig S; Penson T; Zolal A; Thiede C; Schackert G; Krex D; Miller JJ; Cahill DP
J Neurooncol; 2019 Jan; 141(2):327-335. PubMed ID: 30536195
[TBL] [Abstract][Full Text] [Related]
34. T2-fluid-attenuated inversion recovery mismatch sign in lower grade gliomas: correlation with pathological and molecular findings.
Yamashita S; Takeshima H; Kadota Y; Azuma M; Fukushima T; Ogasawara N; Kawano T; Tamura M; Muta J; Saito K; Takeishi G; Mizuguchi A; Watanabe T; Ohta H; Yokogami K
Brain Tumor Pathol; 2022 Apr; 39(2):88-98. PubMed ID: 35482260
[TBL] [Abstract][Full Text] [Related]
35. Multicenter clinical radiomics-integrated model based on [
Zhang L; Pan H; Liu Z; Gao J; Xu X; Wang L; Wang J; Tang Y; Cao X; Kan Y; Wen Z; Chen J; Huang D; Chen S; Li Y
Eur Radiol; 2023 Feb; 33(2):872-883. PubMed ID: 35984514
[TBL] [Abstract][Full Text] [Related]
36. The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study.
Broen MPG; Smits M; Wijnenga MMJ; Dubbink HJ; Anten MHME; Schijns OEMG; Beckervordersandforth J; Postma AA; van den Bent MJ
Neuro Oncol; 2018 Sep; 20(10):1393-1399. PubMed ID: 29590424
[TBL] [Abstract][Full Text] [Related]
37. The reliability and interobserver reproducibility of T2/FLAIR mismatch in the diagnosis of IDH-mutant astrocytomas.
Yeniçeri İÖ; Yıldız ME; Özduman K; Danyeli AE; Pamir MN; Dinçer A
Diagn Interv Radiol; 2021 Nov; 27(6):796-801. PubMed ID: 34792037
[TBL] [Abstract][Full Text] [Related]
38. Quantitative relaxometry using synthetic MRI could be better than T2-FLAIR mismatch sign for differentiation of IDH-mutant gliomas: a pilot study.
Kikuchi K; Togao O; Yamashita K; Momosaka D; Kikuchi Y; Kuga D; Hata N; Mizoguchi M; Yamamoto H; Iwaki T; Hiwatashi A; Ishigami K
Sci Rep; 2022 Jun; 12(1):9197. PubMed ID: 35654812
[TBL] [Abstract][Full Text] [Related]
39. Magnetic resonance imaging texture analyses in lower-grade gliomas with a commercially available software: correlation of apparent diffusion coefficient and T2 skewness with 1p/19q codeletion.
Kanazawa T; Minami Y; Takahashi H; Fujiwara H; Toda M; Jinzaki M; Yoshida K; Sasaki H
Neurosurg Rev; 2020 Aug; 43(4):1211-1219. PubMed ID: 31402410
[TBL] [Abstract][Full Text] [Related]
40. Glioma grading prediction using multiparametric magnetic resonance imaging-based radiomics combined with proton magnetic resonance spectroscopy and diffusion tensor imaging.
Lin K; Cidan W; Qi Y; Wang X
Med Phys; 2022 Jul; 49(7):4419-4429. PubMed ID: 35366379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
